Therefore, the current results suggest that CC and/or metformin may also contribute to a reduction in hyperglycaemia by regulating gluconeogenic PEPCK enzyme levels in the ZDF rats, with insulin signalling playing a role in this process. This evidence concerns the gene PCK2 and Hyperglycemia.